Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: J Biomed Mater Res A. 2010 Jun 1;93(3):1110–1123. doi: 10.1002/jbm.a.32601

Figure 6.

Figure 6

Viability of hMSCs cultured in wells of non-degrading PEG hydrogel arrays containing A) 0.1mM IKVAV ligand with variable concentrations of FGF-2, and B) 2.5mM IKVAV ligand with variable concentrations of FGF-2. *Denotes a significant difference compared to 0 ng/ml condition at the same time point, ANOVA p<0.05.